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Abstract This review focuses on how measured pre- and
perinatal environmental and (epi)genetic risk factors are
interrelated and potentially influence one, of many, com-
mon developmental pathway towards ADHD. Consistent
with the Developmental Origins of Health and Disease
hypothesis, lower birth weight is associated with increased
ADHD risk. Prenatal ischemia-hypoxia (insufficient blood
and oxygen supply in utero) is a primary pathway to lower
birth weight and produces neurodevelopmental risk for
ADHD. To promote tissue survival in the context of
ischemia-hypoxia, ischemia-hypoxia response (IHR) path-
way gene expression is altered in the developing brain and
peripheral tissues. Although altered IHR gene expression is
adaptive in the context of ischemia-hypoxia, lasting IHR
epigenetic modifications may lead to increased ADHD risk.
Taken together, IHR genetic vulnerability to ischemia-hy-
poxia and IHR epigenetic alterations following prenatal
ischemia-hypoxia may result in neurodevelopmental
vulnerability for ADHD. Limitations of the extant literature
and future directions for genetically-informed research are
discussed.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a
chronic health condition characterized by persistent, per-
vasive, and developmentally inappropriate levels of inat-
tention, hyperactivity-impulsivity, or both (American
Psychiatric Association 2013). ADHD has an average
prevalence rate of 5–5.5 % in youth (Polanczyk et al.
2007), is more common in males (Polanczyk et al. 2007),
and generally persists into adulthood (Barbaresi et al.
2013). It is also associated with high rates of psychiatric
comorbidity (Angold et al. 1999). The economic impact of
ADHD in the United States is an estimated $143–$266
billion annually (Doshi et al. 2012). In order to reduce the
ADHD public health burden, there is a critical need to
further understand the complex origins of ADHD and early
etiological pathways to neurodevelopmental vulnerability.
Comprehensive theories of ADHD (Nigg 2005;
Sonuga-Barke 2002) focus on multiple neurodevelopmen-
tal pathways to ADHD and provide a framework to con-
ceptualize phenotypic heterogeneity within ADHD.
Multiple genetic and prenatal environmental risk factors
for ADHD have been identified; however, it is unclear how
genetic and environmental risk factors coalesce to alter
ADHD risk. Researchers have begun to examine how
genetic pathways may impact molecular and cellular pro-
cesses and ADHD risk (Poelmans et al. 2011; Yang et al.
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2013); however, there remains a significant need to
understand the role of prenatal environmental risk factors
in the etiology of ADHD (Nigg 2012).
Building on previous work linking prenatal hypoxia to
ADHD (Lou 1996; Toft 1999), this paper focuses on the
interplay between genetic, epigenetic, and environmental
risk to examine molecular pathways to ADHD, with a
specific focus on the ischemia-hypoxia response pathway.
To this end, we first briefly review empirical evidence and
theory implicating prenatal ischemia-hypoxia (e.g.,
preeclampsia) and perinatal ischemia-hypoxia (e.g., birth
asphyxia) in the development of ADHD and other neu-
rodevelopmental disorders. Next, we focus on the potential
role of genetic and epigenetic variation in genes shown to
be involved in the ischemia-hypoxia response. Last, we
review the similarities between neurodevelopmental
sequelae of ischemia-hypoxia and neurodevelopmental
correlates of ADHD. We conclude by discussing important
methodological issues in this domain and suggestions for
future research. The goal of the proposed model is to
partially account for etiological heterogeneity in ADHD by
articulating a putative developmental pathway from pre-
and perinatal ischemia-hypoxia to ADHD risk.
Lower birth weight and ADHD risk: Pre-
and perinatal ischemia-hypoxia as a shared
determinant
Birth weight and ADHD risk
Lower birth weight is associated with a wide-range of
chronic health and behavioral conditions (Boulet et al.
2011; Gluckman and Hanson 2004) and is one of the
strongest, and most studied, risk factors for ADHD (Nigg
et al. 2010; Thapar et al. 2013). There is a dose–response
relationship between lower birth weight and ADHD risk
that is continuous in nature (Boulet et al. 2011; Phua et al.
2012; van Os et al. 2001). In addition, birth weight is
associated with increased risk for ADHD over and above
gestational age (Lahti et al. 2006). When examined cate-
gorically, low birth weight (\2500 g) is associated with an
approximately two to threefold increase in ADHD risk
(Breslau et al. 1996; Linnet et al. 2006; Mick et al. 2002)
after adjusting for covariates including child sex, SES,
maternal stress, parental psychopathology, substance
abuse, and maternal smoking (Breslau et al. 1996; Elgen
et al. 2003; Horwood et al. 1998; Indredavik et al. 2004;
Linnet et al. 2006; Zubrick et al. 2000). Further, sibling
comparison (Class et al. 2014) and discordant twin studies
(Ficks et al. 2013; Groen-Blukhuis et al. 2011; Hultman
et al. 2007) indicate that the relationship between birth
weight and ADHD is not accounted for by genetic factors
alone. Despite the well-established association between
lower birth weight and ADHD, there is a paucity of
research examining etiological pathways that both limit
fetal growth and increase ADHD risk.
Prenatal ischemia-hypoxia, birth weight, and ADHD
risk
The relationship between lower birth weight and ADHD is
likely driven by precipitating environmental and genetic
factors. Prenatal ischemia-hypoxia, or an insufficient sup-
ply of nutrients and oxygen to the developing fetus, is a
primary pathway to lower birth weight (Henriksen and
Clausen 2002; Kinzler and Vintzileos 2008) and prematu-
rity (Salmaso et al. 2014). Prenatal ischemia-hypoxia is
implicated in a range of neurodevelopmental disorders,
including ADHD (Getahun et al. 2013; Owens and Hin-
shaw 2013), autism (Gardener et al. 2009; Kolevzon et al.
2007), schizophrenia (Mittal et al. 2008; Schmidt-Kastner
et al. 2012; Schmidt-Kastner et al. 2006), and cerebral
palsy (Derrick et al. 2007; Mwaniki et al. 2012). In par-
ticular, obstetric complications associated with reduced
nutrient and oxygen supply during the prenatal period (e.g.,
preeclampsia) or perinatal period (e.g., birth asphyxia)
increase risk for ADHD (Getahun et al. 2013; Pineda et al.
2007) and ADHD-related comorbidity (Owens and Hin-
shaw 2013). Furthermore, multiple prenatal environmental
risk factors for ADHD (Froehlich et al. 2011), such as
maternal smoking (Bush et al. 2000; Knopik 2009, 2010;
Knopik et al. 2005, 2012, 2015, 2016) and maternal alcohol
use (Bosco and Diaz 2012; Knopik et al. 2006) also lead to
restricted fetal growth, partially through prenatal ischemia-
hypoxia (Table 1). Genetically informed studies, however,
demonstrate that the relationship between prenatal envi-
ronmental risk factors, birth weight and ADHD is complex,
and are at least partially accounted for by genetic factors
(e.g., Thapar et al. 2009; Knopik et al. 2005, 2015, 2016).
Taken together, ischemia-hypoxia during pregnancy and
delivery results from a range of obstetric conditions and
fetal exposures, which limit fetal growth, and may account
for a substantial portion of the ADHD disease burden
(Fig. 1).
Ischemia-hypoxia response (IHR)
In response to prenatal ischemia-hypoxia, the placental-
fetal unit initiates a cascade of responses to preferentially
allocate oxygen and nutrients to promote survival (Murray
2012). Exposure to ischemia-hypoxia leads to changes in
metabolic demand (Murray 2012; Wheaton and Chandel
2011), angiogenesis (Shibuya 2008), inflammatory/im-
mune response (Ellison et al. 2005), neuroprotective/neu-
rotoxic systems (Myint et al. 2007), oxidative stress
(Prabakaran et al. 2004), and blood flow redistribution
(Roza et al. 2008). Importantly, all of these processes are
also implicated in the etiology of ADHD (Lesch et al.
2013; Lou 1996; Lou et al. 2004; Oades 2011; Oades et al.
2010; Ribases et al. 2008; Roza et al. 2008; Sanchez-Mora
et al. 2010; Todd and Botteron 2001). Collectively, the
ischemia-hypoxia response (IHR) may function to mini-
mize damage to neural tissue from an ischemic-hypoxic
pre- and perinatal environment.
Neurodevelopmental outcomes following ischemia-hy-
poxia exposure, however, are highly variable. Therefore, it
is critical to identify genetic and epigenetic factors that
might moderate or mediate the association between
ischemia-hypoxia and ADHD. Most previous gene by
environment interaction (GxE) studies in ADHD selected
candidate genes that have shown an association with the
disorder (see Nigg et al. 2010; for a review). This approach
has a limited conceptual basis and may be related to the
inconsistent findings in the ADHD GxE literature (Ficks
and Waldman 2009). In contrast, candidate genes or
pathways should be selected based on converging evidence
from multiple sources (Dick et al. 2015), including their
functional significance in relation to the putative environ-
mental pathogen (Moffitt et al. 2005)—in this case, pre-and
perinatal ischemia-hypoxia. We have shown that SNPs in
angiogenic (NRP1 & NRP2), neurotrophic (NTRK1 &
NTRK3), and inflammatory genes (CCBL1, CCBL2, IL16,
S100B) moderate the association between birth weight
centile and ADHD symptom severity (Smith et al. 2014).
These genetic systems have been implicated in the ische-
mia-hypoxia response and analyses in BrainCloud
(Colantuoni et al. 2011) suggest many of these genes are
expressed in the prefrontal cortex at relatively higher
levels during prenatal development compared to later
Table 1 Population
attributable fractions (PAF) for
ischemia-hypoxia related pre-
and perinatal environmental risk
factors and ADHD
Risk factor Adj. RR estimate PAF estimate (%)
Low birth weight (\2500 g) 2.85a 12.8b
Maternal smoking 1.53c 7.0b
Maternal alcohol use/non-FAS spec 5.00b 2.4b
Adj. OR estimate PAF estimate (%)
Preeclampsia 1.34d 2.5d
Prolapsed/nuchal cord 1.13d 2.0d
Placental abruption 1.16d 0.2d
Breech/transverse presentation 1.13d 0.7d
Respiratory distress syndrome 1.47d 0.6d
Neonatal resuscitation 2.75d 0.4d
Apgar score of\7 at 5 min 1.31d 0.3d
Fetal dystocia 1.11d 0.2d
Adj RR adjusted relative risk, Adj OR adjusted odds ratio, PAF population attributable fraction—the
percentage of ADHD cases attributed to a given risk factor. Relative risk and odds ratio estimates are
derived from single studies and may overestimate the true association between a risk factor and ADHD;
however, attempts were made to limit such biases (see Nigg 2006, pp. 226–241; Getahun et al. 2013)
a Breslau et al. 1996
b Nigg 2006
c Linnet et al. 2003
d Getahun et al. 2013
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Fig. 1 Prenatal ischemia-hypoxia and the ischemia-hypoxia response
are predicted to underlie the association between lower birth weight
and ADHD. This model depicts how chronic prenatal ischemia-
hypoxia partially determines the association between lower birth
weight and attention-deficit/hyperactivity disorder (ADHD) risk.
Acute pre- or perinatal ischemia-hypoxia (e.g., umbilical cord
prolapse) may still contribute to ADHD risk; however, birth weight
may not be affected. IHR ischemia hypoxia-response
development (See Supplementary Fig. 1). This provides
preliminary evidence that developmental systems involved
in the ischemia-hypoxia response are associated with
ADHD risk and effects likely depend on prenatal envi-
ronmental influences.
Additionally, bioinformatic tools (Viswanathan et al.
2008) can assist in the identification of specific genes and
genetic pathways that are implicated in the IHR. Of partic-
ular interest are genes that are functionally related to hypoxia
inducible factor 1 or 2 (HIF-1; HIF-2), which regulate the
cellular response to hypoxia and are expressed in the brain.
HIFs promote adaptation to hypoxic conditions by regulating
the transcription of IHR genes (Sharp and Bernaudin 2004),
which confer neurological and vascular adaptation (Sch-
midt-Kastner et al. 2006; Schmidt-Kastner et al. 2012; Sharp
and Bernaudin 2004). HIF-1 is necessary for normal
embryonic (Yu et al. 1999), neural, and vascular develop-
ment (Tomita et al. 2003). In addition, the vascular
endothelial growth factor family is the main regulator of
angiogenesis (i.e., the formation of new blood vessels; Shi-
buya 2008; Shibuya and Claesson-Welsh 2006). The
angiogenic system is implicated in ADHD etiology (Jesmin
et al. 2004; Smith et al. 2014) and is upregulated in response
to hypoxia, a process that ismediated byHIFs (MacGabhann
and Popel 2008) and epigenetic mechanisms (Mimura et al.
2012; Skowronski et al. 2010). Although the IHR aims to
protect neural tissue from ischemia-hypoxia, IHR effects
may persist and alter susceptibility for neurodevelopmental
disorders later in life.
Developmental origins of ADHD: Epigenetic
programming and neurodevelopmental risk
The Developmental Origins of Health and Disease
hypothesis (DOHaD; Gluckman and Hanson 2004; Mill
and Petronis 2008; Nigg 2012; Swanson and Wadhwa
2008) builds on the theory of ‘‘fetal programming’’ (Barker
2007) and provides an integrative framework to concep-
tualize the interplay between environmental, genetic and
epigenetic factors in determining birth and health out-
comes. Briefly, DOHaD posits that the prenatal environ-
mental influences are associated with birth outcomes. This
association is presumed to be mediated by epigenetic
changes which allow the developing fetus to adapt the
structure and function of developmental systems to pro-
mote survival. Additionally, prenatal environmental influ-
ences may disrupt or constrain developmental plasticity
(see Gluckman and Hanson 2004). To the extent that there
is a mismatch between the prenatal and postnatal envi-
ronments the individual may be ill-quipped to function
adaptively in the postnatal environment. This mismatch
confers vulnerability for later disease as the organism is
functioning in an environment for which it was not epi-
genetically programmed to be adaptive in.
From a DOHaD perspective, the association between
lower birth weight and ADHD may arise from a milieu of
obstetric complications which lead to pre- and perinatal
ischemia hypoxia. The placental-fetal unit will adapt to the
ischemic-hypoxic environment by altering the structure
and function of developmental systems, including the
brain. Further, prenatal ischemia-hypoxia may lead to
neural disruption (e.g., intraventricular hemorrhage; Whi-
taker et al. 2011) or place constraints on neurodevelop-
mental processes (e.g., cerebral blood flow; Fu and
Olofsson 2011). At the molecular level, the IHR response
functions to promote survival in the context of cerebral
ischemia-hypoxia. Consistent with DOHaD, however, the
IHR response may leave ADHD-related brain regions ill-
equipped to function in a nutrient and oxygen rich postnatal
environment, increasing ADHD risk later in life. IHR
genetic variability and ischemia-hypoxia induced epige-
netic changes (described below) may confer increased risk
or protection from ADHD, following pre- and perinatal
environmental risk exposure (Mill and Petronis 2008).
Ischemia-hypoxia induced epigenetic effects
Epigenetic mechanisms are a primary mechanism linking
adverse intrauterine environments with later risk for dis-
ease (Wadhwa et al. 2009). Epigenetic changes in DNA
methylation, histone modifications, and noncoding RNA
have been shown, in part, to be induced by exposure to
prenatal ischemia-hypoxia and alter gene expression
(Watson et al. 2010). Ischemia-hypoxia induced epigenetic
alterations are maintained in the absence of HIFs (Tsai and
Wu 2013; Watson et al. 2010), suggesting they may con-
tinue to impact behavioral phenotypes later in life. DNA
methylation, for example, is the addition of a methyl group
to a cytosine in cytosine/guanine-rich DNA regions
(Maccani and Marsit 2009). When cytosines in the gene’s
promoter region are methylated, gene expression is gen-
erally reduced or silenced. Of note, lasting changes in
global DNA methylation are observed in the rat brain
following cerebral ischemia-hypoxia (Wu et al. 2013).
Taken together, decreased nutrient and oxygen availability
in utero may alter IHR gene expression (Schmidt-Kastner
et al. 2012), through HIFs and epigenetic mechanisms,
leading to altered susceptibility for ADHD and related
outcomes (Wang et al. 2013).
Pre- and perinatal ischemia-hypoxia
and neurodevelopmental risk
Pre- and perinatal ischemia-hypoxia leads to lasting chan-
ges in neurodevelopmental functioning, especially in males
(Mueller and Bale 2008). This phenomenon may partially
account for ADHD male preponderance (Jesmin et al.
2004; Laplante et al. 2012) and persistence overtime. Thus,
it is critical to understand neurodevelopmental sequelae of
prenatal ischemia-hypoxia and their relation to ADHD
vulnerability. We briefly address four areas we believe to
be of neurodevelopmental importance below: (i) neu-
roanatomical alterations, (ii) neurotransmission perturba-
tion, (iii) neuroinflammation, and (iv) cerebral vascular
response.
Neuroanatomical alterations
In animal models, chronic pre- and perinatal ischemia-
hypoxia is associated with reductions in brain weight,
myelination, neurogenesis, synaptogenesis, and white
matter damage (Bassan et al. 2010; Mallard et al. 1999), as
well as delays in interneuron, astroglia, and oligoden-
droglia maturation (Salmaso et al. 2014). Generally, these
findings persist into adulthood (Rehn et al. 2004).
Numerous human studies highlight the association between
fetal growth restriction (an indicator of pre- and perinatal
ischemia-hypoxia) and neuroanatomical and neurocogni-
tive outcomes. For instance, in a population-based study,
lower birth weight predicted decreased anterior cingulate,
caudate and total brain volume in childhood (Walhovd
et al. 2012). Additionally, growth-restricted infants have
reductions in overall white and gray matter compared to
infants in the normal birth weight range (Brown et al. 2009;
Larroque et al. 2003; Tolsa et al. 2004). These neu-
roanatomical findings relate to poor performance on mea-
sures of inattention and impulsivity (Peterson et al. 2003;
Tolsa et al. 2004) and are consistent with neurocognitive
findings in ADHD samples (Filipek et al. 1997; Kates et al.
2002; Mostofsky et al. 2002; Overmeyer et al. 2001).
Furthermore, within a low birth weight cohort, immature
white matter lesions and ventricular enlargement, which
are suggestive of ischemia-hypoxia exposure, predicted
increased risk for ADHD (Whitaker et al. 1997, 2011).
Taken together, neurodevelopmental outcomes in pre- and
perinatal ischemia-hypoxia animal models and human
studies suggest neurodevelopmental delays or disruptions,
which are functionally related to ADHD symptomatology.
Neurotransmisssion perturbation
Dopaminergic dysfunction remains of central interest for
the pathophysiology and genetics of ADHD (Biederman
and Faraone 2005; Castellanos and Tannock 2002; Swan-
son et al. 2007). The role of dopaminergic neurons, fibers,
and synapses has been studied in animal models of pre- and
perinatal ischemia-hypoxia (Boksa and El-Khodor 2003).
Loss of dopaminergic neurons has not been observed in
perinatal models, but dysfunction such as imbalances in
dopamine release and abnormal receptor expression have
been reported (Boksa and El-Khodor 2003; Chen et al.
1997; Ungethum et al. 1996). Bjelke et al. (1991) described
increased numbers of tyrosine-hydroxylase positive,
dopaminergic neurons in the substantia nigra in a perinatal
anoxia model. The transcription factor HIF-1 has been
related to the development of nigral dopamine neurons
(Milosevic et al. 2007) and to dopamine toxicity (Lee et al.
2009). Interestingly, dopaminergic neurons of the mouse
substantia nigra and ventral tegmental area express mainly
ARNT as HIF-1 beta subunit and only low levels of
ARNT2, contrasting with dual expression in cortical and
hippocampal neuronal populations (Dela Cruz et al. 2014).
We have speculated that this expression pattern may limit
the reaction of midbrain dopaminergic neurons to hypoxia
(Dela Cruz et al. 2014). In adult rats, lesions can be
observed in the substantia nigra pars reticulata under severe
ischemic conditions whereas the dopaminergic nigral
neurons are resistant (Inamura et al. 1987). The human
striatum is vulnerable to perinatal ischemia-hypoxia (Lou
et al. 2004), and experimental studies show dysmaturation
of striatal projection neurons following pre-natal hypoxia
(McClendon et al. 2014). The interaction between early
striatal damage and dysfunction of the dopaminergic input
remains to be understood. One intriguing hypothesis (Toft
1999) is that subtle damage to frontostriatal circuitry would
lead to specific deficits in sustained attention and response
inhibition underlying ADHD behavioral symptoms and
related functional deficits (Gau et al. 2015). Taken toge-
ther, experimental evidence indicates that pre- and peri-
natal hypoxia can have lasting effects on the dopaminergic
function, whereas neuronal death does not seem to play a
role.
ADHD is also associated with altered glutamatergic
transmission (Elia et al. 2012; Lesch et al. 2013). In con-
trast to findings related to dopaminergic functioning, pre-
natal ischemia-hypoxia leads to energy depletion in the
fetal brain and neuronal apoptosis (cell death) from gluta-
mate-induced excitotoxicity (Back and Rosenberg 2014).
Interestingly, neuronal energy deficiency has also been
proposed as a biological underpinning of ADHD (Todd and
Botteron 2001).
Neuroinflammation
In response to prenatal ischemia-hypoxia and neuronal
apoptosis, the immune system responds by increasing cir-
culating pro-inflammatory cytokines, which further com-
promises fetal brain development (Jellema et al. 2013).
Pro-inflammatory cytokines may lead to increased blood–
brain barrier permeability (Kaur and Ling 2008) and
excessive quinolinic acid, a glutamate receptor agonist,
which at heightened levels is neurotoxic (Myint et al.
2007). Indeed, elevated levels of circulating cytokines in
perinatal development are associated with multiple neu-
rodevelopmental deficits (e.g., Krakowiak et al. 2015),
including ADHD diagnosis (Oades 2011) and ADHD
neurocognitive endophenotypes (Oades et al. 2010).
Cerebral vascular response
Doppler velocimetry studies have shown that, in response
to fetal hypoxia, the fetus increases distribution of blood
flow to the brain (Fu and Olofsson 2006). Though this
‘‘brain-sparing flow’’ may confer survival advantage in the
moment, it is associated with decreased vascular plasticity
in the future (Fu and Olofsson 2006) and increased risk for
ADHD symptoms at 3 years of age (Roza et al. 2008).
Thus, fetal adaptations to prenatal ischemia-hypoxia and
aberrant vascular adaptations may lead to increased vul-
nerability for later neurodevelopmental and behavioral
problems.
Summary and research considerations
Converging lines of evidence indicate that ischemia-hy-
poxia is an early environmental pathogen for ADHD and
related neurodevelopmental outcomes. Ischemia-hypoxia is
a common element of multiple (often viewed as disparate)
prenatal environmental risk factors, including low birth
weight, prematurity, various obstetric complications, and
maternal smoking during pregnancy (Table 1). To promote
the identification of etiological pathways to ADHD, it is
important to consider the physiological sequelae of pre-
natal environmental risk factors. From this perspective,
prenatal ischemia-hypoxia may initiate one common early
etiological pathway to ADHD. Further, the IHR pathway
highlights regions of the genome and epigenome that are
particularly relevant to the development of ADHD, espe-
cially in the context of prenatal environmental risk. Fur-
ther, preliminary evidence suggests that prenatal ischemia-
hypoxia may help to explain male preponderance of
ADHD (Jesmin et al. 2004; Laplante et al. 2012) as well as
phenotypic heterogeneity in ADHD symptomatology (Toft
1999; Gau et al. 2015), persistence (e.g., Wu et al. 2013)
and comorbidity (Owens and Hinshaw 2013).To better
elucidate mechanisms linking pre- and perinatal ischemia-
hypoxia and ADHD, consideration should be given to the
following methodological issues.
First, there is little consensus on the most appropriate
indicators of pre- and perinatal ischemia-hypoxia. Low
birth weight is often utilized as a general proxy for an
adverse intrauterine environment. Low birth weight, how-
ever, is multifactorial and may identify individuals who are
either constitutionally small or premature, but not growth
restricted (Maulik 2006) and not exposed to prenatal
ischemia-hypoxia. Appropriately grown individuals that
are born premature do not appear to be at increased risk for
ADHD (Heinonen et al. 2010). Therefore, in models of
ADHD risk, it is more appropriate to utilize measures of
fetal growth that adjust for gestational age as well as other
covariates (e.g., sex, parity, and ancestry), such as cus-
tomized birth centiles. Customized birth centiles may bet-
ter capture vulnerability for ADHD due to limited nutrient
and oxygen supply in utero compared to birth weight alone
as they provide better estimates of growth potential. This
measurement approach, however, is not proximally related
to prenatal ischemia-hypoxia, prompting the need for more
direct measures of prenatal ischemia-hypoxia in human
studies, such as Doppler ultrasound assessment of fetal
cerebral blood flow (e.g., Roza et al. 2008).
Ischemia-hypoxia related obstetric complications during
pregnancy and birth (see Table 1) may provide a more
accurate measure of ischemia-hypoxia exposure. Creating a
weighted summary score of chronic and acute pre- and
perinatal risk factors allows for ischemia-hypoxia exposure
severity to be measured on a continuum (Getahun et al.
2013; Lewis and Murray 1987). In addition, directly
measuring maternal-placental-fetal blood flow with Dop-
pler ultrasound may provide a more direct measure of
prenatal ischemia (Guvendag et al. 2013; Thuring et al.
2012) at the time of assessment. Further, placental
pathology examination may provide researchers a physio-
logical measure of limited placental-fetal blood and oxygen
flow, which have previously been linked to autism (Walker
et al. 2013). Direct measures of prenatal ischemia-hypoxia
in human studies are sorely needed to increase the public
health impact of research in this domain.
Second, evidence from microarray gene expression
studies in brain tissue of mice implicates a wide-range of
genes in the ischemia-hypoxia response, which may play
an important role in ADHD etiology, especially following
an adverse intrauterine environment. Therefore, a multi-
omic approach is required to examine the interplay
between prenatal environmental risk, genomic, epige-
nomic, and transcriptomic factors. This would involve
integrating genomic, epigenomic and transcriptomic data
within the IHR pathway. Analytical approaches for inte-
grating multi-omic data are still in the early stages of
development (Lasky-Su 2013). In addition, it is unclear
how well epigenetic alternations and gene expression in the
brain relate to levels in peripheral tissues (e.g., blood),
which are accessible in human studies (Day et al. 2013;
Tylee et al. 2013). Studies examining tissue specificity and
temporal stability of IHR epigenetic and expression chan-
ges in response to ischemia-hypoxia are needed. Leverag-
ing developmental gene expression databases (e.g., Allen
Brain Atlas; BrainCloud; BRAINSPAN) will help to target
genes that are relevant to prenatal brain development.
Third, to complement epidemiological studies, there is
critical need to leverage experimental and quasi-experi-
mental designs in animals and humans, respectively.
Experimental methods which leverage inbred strains of
rodents provide the critical methodological control for
genetic differences that otherwise obfuscate environmen-
tally-induced epigenetic and expression differences in the
IHR pathway. Genetically-informed human studies (e.g.,
co-twin, sibling comparisons, and children-of-twin) may
help to further isolate causal prenatal environmental factors
for ADHD and related neurodevelopmental disorders.
Thus, utilizing epidemiological and experimental research
methods in this domain will help to both identify specific
pre- and perinatal environmental causes and molecular
mechanisms linking prenatal ischemia-hypoxia exposure
with ADHD risk.
In conclusion, prenatal ischemia-hypoxia and IHR genes
and epigenetic mechanisms may initiate one, among many,
possible developmental cascades that ultimately increases
risk for ADHD and related neurodevelopmental outcomes.
Multi-omic research linking prenatal ischemia-hypoxia
with lasting neurodevelopmental vulnerability is needed to
better elucidate the role of the IHR pathway in ADHD
vulnerability. Such research may help to identify molecular
mechanisms associated with neurodevelopmental risk/pro-
tection following exposure to an adverse pre- and perinatal
environment. Ultimately, this research may inform pre-
ventative interventions for ADHD targeting individuals
exposed to pre- and perinatal ischemia-hypoxia.
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